Apellis's Empaveli is the first drug to reach the IC-MPGN market and will compete against Novartis' Fabhalta in C3G, another rare kidney disease.

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), including in people without a diagnosis of lupus nephritis (LN, lupus-related ...

The FDA approved pegcetacoplan (EMPAVELI; Apellis Pharmaceuticals) as the first treatment for patients 12 years and older with the rare, severe kidney diseases C3 glomerulopathy (C3G) and primary ...

A Long Island boy battling complete kidney failure became Suffolk County's top cop Tuesday.

FDA mandates GLP-1 drug label updates for kidney injury risk due to dehydration, urging caution for users with gastrointestinal issues.

A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment target for people with lupus nephritis (LN, lupus-related kidney disease).

At 16 years old, Sam Heintz is living out his dream of playing baseball, thanks to a special request from his mother during his kidney transplant procedure.

Stage IV kidney disease leaves you at risk for kidney failure. Learn about this health condition today.

Before receiving her transplant from a living donor, LaQuayia "LQ" Goldring spent up to four and a half hours a day hooked up to a home dialysis machine.

The Kidney Disease Signs One Man Wishes He Noticed Sooner Atkinson noticed a few changes to his body that, in hindsight, he wishes he had flagged because they are early kidney disease signs.